HomeCompareSEEK vs JNJ

SEEK vs JNJ: Dividend Comparison 2026

SEEK yields 2000000.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SEEK wins by $4.879226400974806e+39M in total portfolio value
10 years
SEEK
SEEK
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full SEEK calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SEEK vs JNJ

📍 SEEK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSEEKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SEEK + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SEEK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEEK
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, SEEK beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEEK + JNJ for your $10,000?

SEEK: 50%JNJ: 50%
100% JNJ50/50100% SEEK
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SEEK
No analyst data
Altman Z
-91.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEEK buys
0
JNJ buys
0
No recent congressional trades found for SEEK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSEEKJNJ
Forward yield2000000.00%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4.879226400974806e+39M$30.5K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$4,749.88
Total dividends collected$4.879195005460081e+39M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SEEK vs JNJ ($10,000, DRIP)

YearSEEK PortfolioSEEK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,594$274.49+$200.00MSEEK
2$3,738,731,768,458$3,738,517,757,009.35$11,294$360.69+$3738731.76MSEEK
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,133$476.91+$65315062866.92MSEEK
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,156$635.42+$1066400830062625.00MSEEK
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$14,432$854.61+$16272182796453826560.00MSEEK
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$16,056$1,162.76+$2.3205424011366188e+23MSEEK
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$18,175$1,604.53+$3.0927990661046884e+27MSEEK
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$21,009$2,252.68+$3.8524105697352695e+31MSEEK
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$24,911$3,229.73+$4.484688260147987e+35MSEEK
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$30,458$4,749.88+$4.879226400974806e+39MSEEK

SEEK vs JNJ: Complete Analysis 2026

SEEKStock

TheDirectory.com, Inc. operates as an online local search and directory company in the United States. The company owns and operates a network of online local business directories and city guides, which provide business listings, directory information, and user generated reviews to consumers, who are searching online for services from local businesses through its business search engine, TheDirectory.com. It also operates various vertically targeted directories, such as Podiatrist.net, Chiropractor.net, 123HomeRepair.com, and DentistAppointments.com; and a network of Hello branded city guides, such as HelloNewYorkCity.com, HelloChicago.com, HelloMiami.com, and other guides. In addition, the company provides a suite of online marketing and branding solutions comprising search engine marketing, display advertising, Web presence, and online media and social networking products, as well as designs, develops, and deploys custom-built search engine optimized business Websites. It primarily serves small-and medium-sized businesses, advertisers focused on the local market, agencies, and resellers. The company was formerly known as Elysium Internet, Inc. and changed its name to TheDirectory.com, Inc. in May 2011. The company is based in Tampa, Florida. TheDirectory.com, Inc. is a subsidiary of FTS Group, Inc.

Full SEEK Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SEEK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEEK vs SCHDSEEK vs JEPISEEK vs OSEEK vs KOSEEK vs MAINSEEK vs ABBVSEEK vs MRKSEEK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.